Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Market and Distribute a Tobacco Product

Market and Distribute a Tobacco Product

                        Questions & Answers
          Tobacco Products Marketing Orders
          Deemed New Tobacco Product Applications Lists
          Reviewer Guides and Scientific Policy Memoranda about FDA Review of Tobacco Product Applications
          Supervisory Review/Appeal Process for Tobacco Product Decisions


                        Substantial Equivalence
          Exemption from Substantial Equivalence
          Premarket Tobacco Product Applications Home
          Tobacco Products
          Products, Guidance & Regulations
          Market and Distribute a Tobacco Product
          Submit and Reference Tobacco Product Master FilesMarket and Distribute a Tobacco Product Submit and Reference Tobacco Product Master Files
  
  	
    Share
    Post
    Linkedin

    Email
    Print**On this page:**

Overview of Tobacco Product Master Files (TPMF)
	Preparing and Referencing a TPMF
	TPMF Process
	ResourcesOverview of TPMFs

Tobacco Product Master Files (TPMF) can be submitted by any person. TPMFs are voluntary submissions to the FDA that contain trade secret and/or confidential commercial information about a tobacco product or component that the owner does not want to share with others but may be needed for reference by other parties who are preparing tobacco product submissions. Tobacco Product Master Files are a beneficial tool for manufacturers, component and ingredient suppliers, and researchers, and can assist the tobacco product submission process. When a TPMF is established with FDA, it can be referenced by the TPMF owner and/or an authorized party:

**TPMF owners** can reference their own TPMF rather than submitting the same information separately for multiple submissions.
	**Authorized parties** who have been granted authorization to reference a TPMF by the TPMF owner can reference TPMF data and analyses, such as extensive ingredient lists and constituent testing, in support of a tobacco product submission. The FDA can then access and review the trade secret and/or confidential information as part of the authorized party’s submission without that party seeing or accessing the TPMF owner’s confidential information.Referencing a TPMF file rather than re-creating or submitting similar or duplicate information for each submission may allow both TPMF owners and authorized parties to reduce submission preparation costs.

Examples:

**A flavor supplier** establishes a TPMF containing a full listing of ingredients and composition information of different flavors. The flavor supplier could then grant authorization to a customer to reference the TPMF to support the customer's premarket tobacco application (PMTA) for an e-cigarette that uses the supplier's flavors. When reviewing the PMTA, FDA will review the confidential TPMF ingredient and composition information, without that information being shared to the customer.
	**A laboratory**establishes a TPMF containing protocols and methods to determine the quantities of Harmful and Potentially Harmful Constituents (HPHCs) for new and predicate tobacco products. The laboratory could then grant authorization to a manufacturer to reference the TPMF to support the manufacturer’s substantial equivalence (SE) application.  When reviewing the SE Report, FDA will review the confidential TPMF protocols and HPHC methods, without that information being shared to the manufacturer.
	**A cigarette manufacturer** establishes a TPMF containing all of the design parameters for one of their predicate tobacco products. The TPMF also contains evidence to demonstrate that the product was on the market as of February 15, 2007. The TPMF owner may reference its own TPMF in 50 SE applications, rather than submitting the predicate tobacco product information multiple times. When reviewing the SE Report FDA will review the TPMF to adequately characterize the predicate product and make a determination of predicate eligibility.Common submissions that may reference TPMFs include but are not limited to:

Premarket Tobacco Applications (PMTA)
	Substantial Equivalence (SE)
	Modified Risk Tobacco Product Applications (MRTPA)
	Exemption from SE Requirements (EX REQ)
	Pre-Existing Tobacco Products
	Use of Investigational Tobacco Products
	Listing of Ingredients in Tobacco ProductsPreparing and Referencing a TPMF

A TPMF should include:
	Cover letter that contains:
		A statement that the information is being submitted as TPMF
		A brief description of the TPMF content
		Name and contact information for the TPMF owner
		If submitted by an authorized representative, the name and contact information for the authorized representative
		Signature of the TPMF owner or authorized representative, who resides in or has a place of business in the U.S.
		If submitted by a non-attorney representative, include the TPMF owner’s authorization (e.g., on TPMF owner’s letterhead);
			If submitted by an attorney, include attorney declaration and authorization (e.g., “I am submitting on behalf of...”)
		If the TPMF owner or authorized representative does not reside in or have a place of business in the United States, the name and contact information for a U.S. agent
		Table of contents
		The information that will be included in the TPMF (e.g. tobacco product information, manufacturing and processing data, research findings)
		List of each person currently authorized to reference the TPMF including name and contact information
		Identification of any limitations on each authorization (e.g., if the TPMF owner is authorizing others to use only certain sections and, if so, identification of those sections).
	We recommend the following structure:
	Cover letter and Administrative Information
		Table of contents
		Summaries
		Product Description and Manufacturing (if applicable)
		Nonclinical (if applicable)
		Clinical – Product Impact on Individual Health (if applicable)
		Clinical – Product Impact on Population Health (if applicable)
		Environmental Impact (if applicable)**How to Submit a TPMF**

	Online:
		Request an Industry Account Manager (IAM) account to establish a CTP Portal account, if your company does not already have an IAM.
			Prepare your submission electronically using FDA's eSubmitter software and the eSubmitter template “CTP Transmittal Form.”
			Submit online via the CTP Portal*Note:* The CTP Portal provides more functionality than the ESG, and CTP recommends using the CTP Portal. However, if you already have an ESG WebTrader account, you may use it to submit documents to CTP.
		Submit by Mail: If you are unable to submit online, mail submissions to CTP's Document Control Center.
	**Amendments to a TPMF** Amendments can be submitted using the above instructions.   The amendment should include a cover letter that includes the STN(s) of the TPMF in the subject line.  If responding to a deficiency (including requests), follow the instructions as outlined in your deficiency letter.
	**Grant Authorization to Reference a TPMF** The TPMF owners or authorized representatives may grant parties the right to reference a TPMF through a letter of authorization (LOA). An LOA is submitted to FDA on the TPMF owner’s letterhead and includes the following:
	TPMF submission tracking number
		Limitations to the authorized party’s authorization
		Location within the TPMF of the section being authorized as right of reference
		Signature of the TPMF owner or authorized representativeFDA recommends the TPMF owner also provide a copy of the LOA to the authorized party for inclusion in their submission.

**Reference a TPMF**
	FDA recommends that the authorized party include the following when referencing a TPMF:
	A notation in the cover letter of the TPMF STN being referenced
		If possible, where the information being referenced is located in the TPMF
		A copy of the LOATPMF Process

Tobacco Product Master Files Process
**Establishment**:  When a request to establish a TPMF is submitted to CTP. Establishing a TPMF with FDA does not mean the data contained within has been validated by FDA and does not equate to any conclusion regarding its contents.

	Output
		Acknowledgement letter, or
			General correspondence letter: provides information if information does not allow for a TPMF to be established
	**Scientific Review**: When a submission appropriately references a TPMF, FDA intends to conduct scientific review of the information referenced. 
	Output
		None required
	**Determination**: During review, FDA determines the information referenced in the TPMF is adequate or inadequate for the submission that is referencing it.
	Output 
		Deficiency letter: Additional information is needed or will be helpful in making a decision on a submission which references a TPMF. Depending on the type of application referencing the TPMF, TPMF owners have between 30-180 days to respond to this type of letter.
	**Closure:** When FDA initiates closure of a TPMF if it has not been active or referenced in a three-year period.  
	Output
		Notification letter: Notifies the TPMF owner of the intent to close and provides a timeframe for response.
			Closure letter: Letter closing the TPMF. Once a TPMF is closed, authorized parties are unable to reference the TPMF in support of its submissions. FDA will not review the TPMF in support of a submission.Resources

Guidance
	Tobacco Product Master Files: Guidance for Industry
	Webinar
	Using a TPMF for Ingredient Listing Submissions
	Reference Tools
	Tobacco Product Master Files (TPMFs): Presentation from 2018 Tobacco Product Application Review Public Meeting
		Q&A: Tobacco Product Review and Evaluation—Pathways to Market
		Tobacco Product Marketing Orders
		Information and Resources on Application Review Programs: Presentation from 2018 Tobacco Product Application Review Public Meeting
		CTP Electronic Submissions Standards and Activities: Presentation from 2018 Tobacco Product Application Review Public MeetingAdditional Resources

Tobacco Control Act
	Scientific Policy Memoranda about FDA Review
	Manufacturing
	Small Business Assistance for Tobacco Product Industry
	CTP Ombudsman

                                                                                  Content current as of:
      06/17/2020
              
              
Regulated Product(s)
		 TobaccoMarket and Distribute a Tobacco Product

          
                        Questions & Answers
          Tobacco Products Marketing Orders
          Deemed New Tobacco Product Applications Lists
          Reviewer Guides and Scientific Policy Memoranda about FDA Review of Tobacco Product Applications
          Supervisory Review/Appeal Process for Tobacco Product Decisions


                        Substantial Equivalence
          Exemption from Substantial Equivalence
          Premarket Tobacco Product Applications
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop